Bill Wilson: Debating GLP-1 Drugs—Do They Permanently Curb Cravings or Require Lifelong Use?
A short transcript excerpt from a YouTube conversation between Dr. Ron Najafi and Bill Wilson about whether GLP-1 drugs must be taken continuously to maintain weight loss. Dr. Najafi asserts weight is regained after stopping the drugs; Bill Wilson challenges that absolute view, arguing that for "carb syndrome" symptoms stem from depletion of monoamine-related nutrients and can be treated with precursor supplements (he names Carb22 and Apocer) to reduce cravings and improve mental function.
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet